RECRUITING

Advanced Diffusion Imaging in Renal Cancer Patients

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The objective of this study is to apply advanced diffusion imaging in a two-pronged assessment of renal mass patients: (1) characterization of lesion malignancy and subtype, and (2) prediction of renal function stability or decline following partial nephrectomy.

Official Title

Advanced Diffusion Imaging in Renal Cancer Patients: Oncologic Control and Renal Functional Reserve

Quick Facts

Study Start:2022-12-01
Study Completion:2028-12-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06116253

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Renal mass patients scheduled for laparoscopic partial nephrectomy.
  2. * eGFR above 30 ml/min/m2.
  3. * Ages 21 to 85
  4. * Must be willing and able to provide consent.
  1. * All metal implants and dental implants that have ferromagnetic properties and are unsafe at 3.0 T.
  2. * Pregnant women are not eligible for participating in this study.
  3. * Acute claustrophobia

Contacts and Locations

Study Contact

Nalini Jeet
CONTACT
212-263-0228
Nalini.jeet@nyulangone.org
Malika Kumbella
CONTACT
646-501-0075
Malika.kumbella@nyulangone.org

Principal Investigator

Eric Sigmund, PhD
PRINCIPAL_INVESTIGATOR
NYU Langone Medical Center

Study Locations (Sites)

NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Eric Sigmund, PhD, PRINCIPAL_INVESTIGATOR, NYU Langone Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-12-01
Study Completion Date2028-12-01

Study Record Updates

Study Start Date2022-12-01
Study Completion Date2028-12-01

Terms related to this study

Additional Relevant MeSH Terms

  • Renal Cancer